Intervention Review

You have free access to this content

Sulthiame monotherapy for epilepsy

  1. Philip Milburn-McNulty1,*,
  2. Graham Powell1,
  3. Graeme J Sills2,
  4. Anthony G Marson2

Editorial Group: Cochrane Epilepsy Group

Published Online: 9 MAR 2014

Assessed as up-to-date: 24 OCT 2013

DOI: 10.1002/14651858.CD010062.pub2


How to Cite

Milburn-McNulty P, Powell G, Sills GJ, Marson AG. Sulthiame monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010062. DOI: 10.1002/14651858.CD010062.pub2.

Author Information

  1. 1

    The Walton Centre for Neurology & Neurosurgery NHS Foundation Trust, Liverpool, UK

  2. 2

    Institute of Translational Medicine, University of Liverpool, Department of Molecular and Clinical Pharmacology, Liverpool, Merseyside, UK

*Philip Milburn-McNulty, The Walton Centre for Neurology & Neurosurgery NHS Foundation Trust, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK. philmilburnmcnulty@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 9 MAR 2014

SEARCH

[Figure 1]
Figure 1. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Adverse effects (numbers of events), Outcome 1 All adverse effects—sulthiame versus phenytoin.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Adverse effects (numbers of events), Outcome 2 Paraesthesia—sulthiame versus phenytoin.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Adverse effects (numbers of events), Outcome 3 Dizziness—sulthiame versus phenytoin.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Adverse effects (numbers of events), Outcome 4 Headache—sulthiame versus phenytoin.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Adverse effects (numbers of events), Outcome 5 Anorexia—sulthiame versus phenytoin.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Adverse effects (numbers of events), Outcome 6 Rash—sulthiame versus phenytoin.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Adverse effects (numbers of events), Outcome 7 Gingival hyperplasia—sulthiame versus phenytoin.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Adverse effects (numbers of events), Outcome 8 Other—sulthiame versus phenytoin.